Works matching IS 10685308 AND DT 2021 AND VI 32 AND IP 3
1
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 9, doi. 10.1002/pu.30674
- Article
2
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 8, doi. 10.1002/pu.30698
- Article
3
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 8, doi. 10.1002/pu.30697
- Article
4
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 8, doi. 10.1002/pu.30696
- Article
5
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 6, doi. 10.1002/pu.30695
- Article
6
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 6, doi. 10.1002/pu.30694
- Article
7
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 7, doi. 10.1002/pu.30668
- Article
8
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 4, doi. 10.1002/pu.30692
- Article
9
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 3, doi. 10.1002/pu.30691
- Article
10
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 2, doi. 10.1002/pu.30665
- Article
11
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 1, doi. 10.1002/pu.30689
- Article
12
- Brown University Psychopharmacology Update, 2021, v. 32, n. 3, p. 1, doi. 10.1002/pu.30688
- Article